Advertisement

Human chorionic gonadotropin directly and indirectly alters uterine arteriolar diameters in cycling rats

      Abstract

      OBJECTIVE: Our purpose was to investigate whether uterine microvascular responses to human chorionic gonadotropin application depend on route of administration and estrous cycle day. STUDY DESIGN: One uterine horn was exteriorized in pentobarbital-anesthetized cycling and ovariectomized rats and superfused with Krebs solution. Uterine arterioles (64 ± 2.1 μm) were viewed by videomicroscopy. Diameters were measured during a 20-minute baseline period and for 60 minutes during human chorionic gonadotropin suffusion (20 IU/60 ml) or 60 minutes after intraperitoneal injection of 50 IU of human chorionic gonadotropin. Papaverine (100 μmol/L) suffusion maximally dilated the uterine arterioles (80 ± 2.6 μm). RESULTS: Suffusion of human chorionic gonadotropin–dilated arterioles on diestrus-1 (122% ± 2% baseline) and diestrus-2 (118% ± 4% baseline) but constricted arterioles on proestrus (78% ± 7% baseline). Intraperitoneal injection of human chorionic gonadotropin resulted in arteriolar constriction on diestrus-2 (76% ± 5% baseline) and proestrus (82% ± 3% baseline). Ovariectomy eliminated the effects of injected but not suffused human chorionic gonadotropin. All results are significant at p < 0.05. CONCLUSIONS: Results indicate estrous cycle day–dependent direct and indirect effects of human chorionic gonadotropin on the resistance of uterine arterioles. (Am J Obstet Gynecol 1997;176:150-7.)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ziecik AJ
        • Derecka-Reszka K
        • Rzucidlo SJ.
        Extragonadal gonadotropin receptors, their distribution and function.
        J Physiol Pharmacol. 1992; 43: 33-49
        • Lei ZM
        • Reshef E
        • Rao ChV
        The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels.
        J Clin Endocrinol Metab. 1992; 75: 651-659
        • Toth P
        • Li X
        • Rao CV
        • Lincoln SR
        • Sanfilippo JS
        • Spinnato II, JA
        • et al.
        Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries.
        J Clin Endocrinol Metab. 1994; 79: 307-315
        • Bonnamy PJ
        • Benhaim A
        • Leymarie P.
        Estrous cycle-related changes of high affinity luteinizing hormone/human chorionic gonadotropin binding sites in the rat uterus.
        Endocrinology. 1990; 126: 1264-1269
        • Sawitzke AL
        • Odell WD.
        Uterine binding sites for LH/hCG can be modulated by hormonal status in rabbits and rats.
        Acta Endocrinol (Copenh). 1991; 124: 322-330
        • Gafvels M
        • Olofsson J
        • Norjavaara E
        • Selstam G.
        Hormonal influence on utero-ovarian blood flow distribution in the mid-luteal pseudopregnant rat.
        Acta Physiol Scand. 1988; 132: 329-333
        • Hill JB
        • Jimenez AE
        • Passmore JC
        • Rao CV.
        Effect of human chorionic gonadotropin on reproductive organ blood flow in cycling rats.
        Proc Soc Exp Biol Med. 1996; 211: 94-99
        • Battaglia C
        • Larocca E
        • Lanzani A
        • Valentini M
        • Genazzani AR.
        Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles.
        Gynecol Endocrinol. 1990; 4: 245-250
        • Jauniaux E
        • Jurkovic D
        • Delogne-Desnoek J
        • Meuris S.
        Influence of human chorionic gonadotropin, oestradiol and progesterone on uteroplacental and corpus luteum blood flow in normal early pregnancy.
        Hum Reprod. 1992; 7: 1467-1473
        • Norjavaara E
        • Olofsson J
        • Gafvels M
        • Selstam G.
        Redistribution of ovarian blood flow after injection of human chorionic gonadotropin and luteinizing hormone in the adult pseudopregnant rat.
        Endocrinology. 1987; 120: 107-114
        • Wiltbank MC
        • Gallagher KP
        • Dysko RC
        • Keyes PL.
        Regulation of blood flow to the rabbit corpus luteum: effects of estradiol and human chorionic gonadotropin.
        Endocrinology. 1989; 124: 605-611
        • Taylor NJ
        • Clark CL
        Detection of relaxin release by porcine luteal cells using a reverse hemolytic plaque assay: effect of prostaglandins E2 and F, human chorionic gonadotropin, and oxytocin.
        Biol Reprod. 1987; 37: 377-384
        • Sirois J
        • Richards JS.
        Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles.
        J Biol Chem. 1992; 267: 6382-6388
        • Edvinsson L
        • Hardebo JE
        • MacKenzie ET
        • Stuart M.
        Dual action on pial arterioles in situ and the effects of propranolal on the response.
        Blood Vessels. 1977; 14: 366-371
        • Alsip NL
        • Hornung JW
        • Saha PR
        • Hill JB
        • Asher EF.
        A new technique for studying the uterine microvasculature in the rat.
        Am J Obstet Gynecol. 1996; 175: 388-395
        • Espey LL
        • Tanaka N
        • Woodard DS
        • Harper MJK
        • Okamura H.
        Decrease in ovarian platelet-activating factor during ovulation in the gonadotropin-primed immature rat.
        Biol Reprod. 1989; 40: 104-110
        • Feral C
        • Reznik Y
        • Le Gall S
        • Mahoudeau J
        • Corvol P
        • Leymarie P.
        Stimulation of hCG of ovarian inactive renin synthesis in rabbit preovulatory theca cells.
        J. Reprod Fertil Suppl. 1987; 35: 169-181
        • Ferruz J
        • Barria A
        • Galleguillos X
        • Lara HE.
        Release of norepinephrine from the rat ovary: local modulation by gonadotropins.
        Biol Reprod. 1991; 45: 592-597
        • Bonnamy PJ
        • Benhaim A
        • Leymarie P.
        Human chorionic gonadotropin affects tissue levels of progesterone and cyclic adenosine 3`,5`-monophosphate in the metestrus rat uterus in vitro.
        Biol Reprod. 1989; 40: 511-516
        • Robbins A
        • Berkley KJ
        • Sato Y.
        Estrous cycle variation of afferent fibers supplying reproductive organs in the female rat.
        Brain Res. 1992; 596: 353-356
        • Tepper MA
        • Roberts JL
        Evidence for only one β-luteinizing hormone and no β-chorionic gonadotropin gene in the rat.
        Endocrinology. 1984; 115: 385-391
        • Smith MS
        • Freeman ME
        • Meill JD.
        The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy.
        Endocrinology. 1975; 96: 219-226
        • Licht P
        • Cao H
        • Lei ZM
        • Rao CV
        • Merz WM.
        Novel self-regulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta.
        Endocrinology. 1993; 133: 3014-3025
        • Braunstein GD
        • Rasor J
        • Alder D
        • Danzer H
        • Wade ME.
        Serum human chorionic gonadotropin levels throughout normal pregnancy.
        Am J Obstet Gynecol. 1976; 126: 678-681
        • Sorenson TK
        • Williams MA
        • Zingheim RW
        • Clement SJ
        • Hickok DE.
        Elevated second-trimester human chorionic gonadotropin and subsequent adverse pregnancy outcome.
        Am J Med Genet. 1992; 44: 485-486